Eli Lilly and Company (LLY)

Eli Lilly Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5,282	7,268	3,268	2,819	2,067	3,819
Short-Term Investments	-	-	-	109.1	144.8	90.1
Cash & Short-Term Investments	5,282	7,268	3,268	2,928	2,212	3,909
Cash Growth	64.00%	122.40%	11.62%	32.37%	-43.41%	6.17%
Accounts Receivable	18,429	17,760	11,006	9,091	6,896	6,673
Other Receivables	2,748	2,395	2,270	2,246	1,663	1,454
Total Trade Receivables	21,177	20,155	13,276	11,336	8,559	8,127
Inventory	14,529	13,744	7,589	5,773	4,310	3,886
Other Current Assets	13,847	14,462	8,607	5,690	2,954	2,531
Total Current Assets	54,835	55,629	32,740	25,727	18,035	18,452
Net Property, Plant & Equipment	26,540	24,675	17,102	12,914	10,144	8,985
Other Intangible Assets	7,374	6,521	6,166	6,907	7,207	7,692
Goodwill	6,130	5,898	5,770	4,940	4,073	3,892
Long-Term Investments	3,116	2,802	3,216	3,052	2,902	3,213
Other Long-Term Assets	18,581	16,951	13,721	10,467	7,130	6,572
Total Assets	116,576	112,476	78,715	64,006	49,490	48,806

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5,029	5,379	3,229	2,599	1,931	1,671
Accrued Expenses	1,359	2,375	2,094	1,650	1,060	958.1
Short-Term Debt	4,000	1,635	5,117	6,905	1,501	1,538
Other Current Liabilities	26,246	25,839	17,936	16,140	12,647	10,886
Total Current Liabilities	36,634	35,228	28,376	27,293	17,138	15,053
Long-Term Debt	39,370	40,868	28,527	18,321	14,738	15,346
Other Long-Term Liabilities	9,374	9,845	7,540	7,529	6,839	9,252
Total Long-Term Liabilities	48,744	50,713	36,067	25,849	21,576	24,599
Total Liabilities	85,378	85,941	64,443	53,143	38,714	39,651

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	590	590	592	593.6	594.1	596.3
Treasury Stock	-	-	-	-44.2	-50.5	-52.7
Additional Paid-in Capital	6,921	7,346	7,439	7,250	6,921	6,833
Accumulated Other Comprehensive Income	-5,827	-5,871	-7,304	-7,340	-6,858	-7,356
Retained Earnings	29,514	24,470	13,545	10,312	10,043	8,959
Total Common Shareholders' Equity	31,198	26,535	14,272	10,772	10,650	8,979
Minority Interest	-	-	-	91.8	125.6	175.6
Shareholders' Equity	31,198	26,535	14,272	10,864	10,775	9,155
Total Liabilities & Equity	116,576	112,476	78,715	64,006	49,490	48,806

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	43,370	42,503	33,644	25,225	16,239	16,885
Net Cash (Debt)	-38,088	-35,235	-30,376	-22,298	-14,027	-12,976
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-42.41	-39.18	-33.60	-24.68	-15.51	-14.23
Book Value	31,198	26,535	14,272	10,772	10,650	8,979
Book Value Per Share	34.74	29.51	15.79	11.93	11.77	9.85
Tangible Book Value	17,694	14,116	2,336	-1,074	-629.8	-2,605
Tangible Book Value Per Share	19.70	15.70	2.58	-1.19	-0.70	-2.86

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Apr 30, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error